Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oncotarget

Showing results (21-30 of 26,728) with videos related to

Pageof 2,673
Sort By:
Oncotarget|March 30, 2011
Proteotoxic stress targeted therapy (PSTT): induction of protein misfolding enhances the antitumor effect of the proteasome inhibitor bortezomibNickolay Neznanov, Andrei P Komarov, Lubov Neznanova, et al.
Oncotarget|April 2, 2011
miRNA signature of schwannomas: possible role(s) of "tumor suppressor" miRNAs in benign tumorsErdogan Pekcan Erkan, Xandra O Breakefield, Okay Saydam
Oncotarget|March 26, 2011
MDM2 promoter SNP285 and SNP309; phylogeny and impact on cancer riskStian Knappskog, Per E Lønning
Oncotarget|March 17, 2011
Inhibition of SREBP1 sensitizes cells to death ligandsYanina Eberhard, Marcela Gronda, Rose Hurren, et al.
Oncotarget|February 15, 2011
Beta-adrenergic signaling, a novel target for cancer therapy?Hildegard M Schuller
Oncotarget|February 15, 2011
Drug discovery approaches to target Wnt signaling in cancer stem cellsJoshua C Curtin, Matthew V Lorenzi
Oncotarget|February 15, 2011
The requirement of p53 for maintaining chromosomal stability during tetraploidizationChui Chui Ho, Pok Man Hau, Miriam Marxer, et al.
Oncotarget|February 15, 2011
Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotargetInti Zlobec, Alessandro Lugli
Oncotarget|February 11, 2011
P3Kα: a driver of tumor metastasis?Leigh Zawel
Oncotarget|February 11, 2011
FLIP regulation of HO-1 and TNF signalling in human acute myeloid leukemia provides a unique secondary anti-apoptotic mechanismStuart A Rushworth, Lyubov Zaitseva, Susana Langa, et al.
Pageof 2,673

Showing results (21-30 of 26,728) with videos related to

Sort By:
Pageof 2,673
Oncotarget|March 30, 2011
Proteotoxic stress targeted therapy (PSTT): induction of protein misfolding enhances the antitumor effect of the proteasome inhibitor bortezomibNickolay Neznanov, Andrei P Komarov, Lubov Neznanova, et al.
Oncotarget|April 2, 2011
miRNA signature of schwannomas: possible role(s) of "tumor suppressor" miRNAs in benign tumorsErdogan Pekcan Erkan, Xandra O Breakefield, Okay Saydam
Oncotarget|March 26, 2011
MDM2 promoter SNP285 and SNP309; phylogeny and impact on cancer riskStian Knappskog, Per E Lønning
Oncotarget|March 17, 2011
Inhibition of SREBP1 sensitizes cells to death ligandsYanina Eberhard, Marcela Gronda, Rose Hurren, et al.
Oncotarget|February 15, 2011
Beta-adrenergic signaling, a novel target for cancer therapy?Hildegard M Schuller
Oncotarget|February 15, 2011
Drug discovery approaches to target Wnt signaling in cancer stem cellsJoshua C Curtin, Matthew V Lorenzi
Oncotarget|February 15, 2011
The requirement of p53 for maintaining chromosomal stability during tetraploidizationChui Chui Ho, Pok Man Hau, Miriam Marxer, et al.
Oncotarget|February 15, 2011
Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotargetInti Zlobec, Alessandro Lugli
Oncotarget|February 11, 2011
P3Kα: a driver of tumor metastasis?Leigh Zawel
Oncotarget|February 11, 2011
FLIP regulation of HO-1 and TNF signalling in human acute myeloid leukemia provides a unique secondary anti-apoptotic mechanismStuart A Rushworth, Lyubov Zaitseva, Susana Langa, et al.
Pageof 2,673